Inhibition of Glycogen Synthase Kinase 3β as a Treatment for the Prevention of Cognitive Deficits after a Traumatic Brain Injury.

MLA

Farr, Susan A., et al. “Inhibition of Glycogen Synthase Kinase 3β as a Treatment for the Prevention of Cognitive Deficits after a Traumatic Brain Injury.” Journal of Neurotrauma, vol. 36, no. 11, June 2019, pp. 1869–75. EBSCOhost, https://doi.org/10.1089/neu.2018.5999.

APA

Farr, S. A., Niehoff, M. L., Kumar, V. B., Roby, D. A., & Morley, J. E. (2019). Inhibition of Glycogen Synthase Kinase 3β as a Treatment for the Prevention of Cognitive Deficits after a Traumatic Brain Injury. Journal of Neurotrauma, 36(11), 1869–1875. https://doi.org/10.1089/neu.2018.5999

Chicago

Farr, Susan A., Michael L. Niehoff, Vijaya B. Kumar, Deborah A. Roby, and John E. Morley. 2019. “Inhibition of Glycogen Synthase Kinase 3β as a Treatment for the Prevention of Cognitive Deficits after a Traumatic Brain Injury.” Journal of Neurotrauma 36 (11): 1869–75. doi:10.1089/neu.2018.5999.